Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yongzhuo Yu
Institution:
Affiliated Hospital of Qingdao University
Observed institution:
Affiliated Hospital of Qingdao University
ORCID:
0009-0008-5412-5059
Observed ORCID:
0009-0008-5412-5059
OpenAlex ID:
A5020187497
EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner
2024
·
Kuangyang Chen
, Yahao Wang
, et al.
·
Journal of Hepatology
·
21
Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes
2023
·
Yongzhuo Yu
, Wenxuan Li
, et al.
·
Frontiers in Endocrinology
·
20
PDF
Evaluation of the Regulatory Effect of the Pan-PPAR Agonist Chiglitazar on the Dawn Phenomenon
2025
·
Wenxuan Li
, Yangang Wang
, et al.
·
Diabetes Therapy
·
6
Combined obesity- and lipid-related indices are associated with hypogonadism in Chinese male patients with type 2 diabetes: a cross-sectional study
2024
·
Yongzhuo Yu
, Yunyang Wang
, et al.
·
Frontiers in Endocrinology
·
6
PDF
Glucocorticoid impact therapy for recurrent IgG4-related disease with diabetes insipidus as the main manifestation: A case report and literature review
2023
·
Yongzhuo Yu
, Lili Xu
, et al.
·
Medicine
·
5
Comparing Efficacy of Chiglitazar, Pioglitazone, and Semaglutide in Type 2 Diabetes: A Retrospective Study
2025
·
Wenxuan Li
, Yangang Wang
, et al.
·
Diabetes Therapy
·
4
The Neurovascular Unit in Diabetic Retinopathy: The Emerging Role of Pyroptosis and Therapeutic Prospects
2026
·
Yongzhuo Yu
, Shufa Li
, et al.
·
Medicinal Research Reviews
PDF
Show more works
View as search
Works count:
7
Citation count:
62
H-index:
5
I10-index:
2
Year
Topic
Type